Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
- 22 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (11) , 2817-2822
- https://doi.org/10.1016/j.bmcl.2004.03.058
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial FibroblastsJournal of Biological Chemistry, 2003
- The Rel/NF-κB family: friend and foeTrends in Biochemical Sciences, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of ApoptosisThe Journal of Experimental Medicine, 1999
- Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 GeneScience, 1999
- Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient MiceImmunity, 1999
- IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIKScience, 1997
- IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB ActivationScience, 1997
- The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB ActivationPublished by Elsevier ,1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996